Monthly Archives: January 2026

Anovité Strengthens Its Foundation with the Leadership of President Katie Kleinsmith

Bluffdale, Utah – Anovité proudly highlights the leadership of Katie Kleinsmith, President of Anovité, whose oversight of manufacturing, production, and field experience has become a cornerstone of the company’s rapid growth and operational excellence.
As President, Katie Kleinsmith plays a critical role in ensuring that Anovité’s science-driven vision is executed with precision, consistency, and care. From overseeing sourcing and production to managing logistics, incentives, and live events, her leadership ensures that what is promised to the field is delivered — every time.
Operational Excellence That Drives Growth
Katie’s deep understanding of colostrum — from raw sourcing through finished formulation — allows Anovité to operate with a level of transparency and quality control that builds trust with both customers and associates. That trust directly fuels growth.
In an industry where confidence in product integrity drives sales, Katie’s hands-on leadership ensures that Anovité’s formulations remain consistent, scalable, and aligned with demand as the company expands.

“Growth only works when systems can support it,”

says Kleinsmith.

“My role is to make sure the foundation is solid — so the field can run fast without friction.”

The Heart Behind the Field
Beyond operations, Katie Kleinsmith is deeply connected to the associate experience. She oversees Anovité’s incentive trips, leadership events, and field recognition programs —

Read more...

Meet GLP THREE™: THREE International’s Natural Answer to the GLP-1 Movement

THREE International unveiled its newest product, GLP THREE™, during a surprise launch at the company’s Dallas Pro Leadership Conference in Fort Worth, Texas, on January 10.
The announcement marked the pinnacle of the two-day event, introducing the company’s entry into one of the most talked-about categories in wellness today: GLP-1 support.
GLP THREE™ is a science-backed product designed with simplicity in mind, making it easy to use.
The global interest in GLP-1 has surged as consumers seek effective solutions for weight management and metabolic health. While much of the public conversation has centered on pharmaceutical approaches, demand continues to grow for alternatives that align with wellness-focused lifestyles. GLP THREE™ is THREE’s patented, all-natural response to this movement.

Powerful. Patented.
GLP THREE™ is formulated to help reduce food cravings, support weight loss, and maintain lean muscle mass* — key priorities for consumers looking for long-term results rather than short-term fixes. Delivered in an easy-to-take oral format, the product reflects a growing preference for natural, accessible solutions that integrate seamlessly into daily routines.
At the core of GLP THREE™ is MBC-267™, a proprietary, all-natural peptide complex, derived from wild caught salmon in the heart of the Nordic sea, and mushrooms.
Little Bottle, Big Results.
The formulation is

Read more...

Zinzino Announces Merger of It Works! For Increased Distribution Power in North America and Europe

Zinzino announces merger of It Works! into the Zinzino family of businesses for increased distribution power in North America and Europe
Zinzino (publ) (ZZ-B.ST) has today entered into an agreement, and simultaneously closed, to combine with the US-based direct sales company It Works! In an all-share transaction. Through the merger, Zinzino acquired the operational assets of It Works!’ US business, including inventory, distributor agreements, customer agreements, and IP rights, as well as 100% of the shares in It Works! Marketing International UC, an Irish unlimited company, and its wholly owned subsidiaries.
The fixed purchase price amounts to USD 30 million (the “Purchase Price”) which has been paid by Zinzino through a directed set-off issue of 1,843,840 B-shares in Zinzino (the “Directed Issue”). The Directed Issue has been resolved upon by the board of directors of Zinzino, based on the authorization of the Annual General Meeting. The subscription price in the Directed Issue amounts to SEK 145.62 per B-share, which corresponds to the volume weighted average price of Zinzino’s B-share two business days prior to the signing and closing of the transaction. In addition, an additional purchase price estimated to USD 4 million could be paid to It Works! during a five-year span

Read more...